Skip to main content

Fluarix News (Page 3)

FDA Approves GlaxoSmithKline's Fluarix Quadrivalent - Four-strain Seasonal Influenza Vaccine for Use in the U.S.

LONDON, Dec. 17, 2012 /PRNewswire/ -- GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX® QUADRIVALENT (Influenza Virus V...

FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use

SILVER SPRING, Md., Oct. 19 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved use of the seasonal influenza vaccine Fluarix for children ages 3 years to 17 years....

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Influenza Prophylaxis

Fluarix patient information at Drugs.com